# Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell

Source: https://onco.cc/trials/nct06441344/  
OnCo record `nct06441344` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of toripalimab and anlotinib in lung cancer, run by Taizhou Hospital, not yet recruiting.

## Summary

Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell is a phase 3, randomised interventional study registered as NCT06441344 by Taizhou Hospital, with a registry enrolment figure of 136 participants, started 2024-07-01 and due to reach its primary completion in 2026-05-01. Interventions recorded: Toripalimab plus Anlotinib; Toripalimab. Conditions listed: SCLC; Maintenance Treatment. Primary outcome: progression free survival(PFS); overal survival time(OS). Lung eligibility wording from the registry: "* Confirmed as small cell lung cancer (SCLC) by histopathology or cytology and diagnosed as extensive after systemic evaluation". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Also known as: SCLC
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06441344
- Phase: 3
- Setting: First-line Etoposide Combined With Platinum-based Chemotherapy Followed by Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell Carcinoma - A Randomized, Controlled, Multicenter Phase III Clinical Study
- Sponsor: Taizhou Hospital
- Enrolled: 136

## Sources

- ClinicalTrials.gov NCT06441344: https://clinicaltrials.gov/study/NCT06441344

## Connected records

- cancers: [Extensive-stage small-cell lung cancer](https://onco.cc/cancers/extensive-stage-sclc/)
- technologies: [Anti-angiogenic therapy](https://onco.cc/technologies/antiangiogenic/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Anlotinib](https://onco.cc/drugs/anlotinib/), [Toripalimab](https://onco.cc/drugs/toripalimab/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06441344.json